Elevated serum interleukin-6 (IL-6) is derived from neoplastic lymphoid cells in patients with B-cell non-Hodgkin's lymphoma: Correlation with extent of IL-6 expression and serum concentration

British Journal of Haematology

Volumn 92, Issue 4, 1996, Pages 1014-1021

  Kato, Hirokazu ^a   Kinoshita, Tomohiro ^a   Suzuki, Sadao ^b   Nagasaka, Tetsuro ^a   Murate, Takashi ^a   Saito, Hidehiko ^a   Hotta, Tomomitsu ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

endogenous source; IL 6 mRNA; semi quantitative reverse transcription polymerase chain reaction; serum IL 6 concentration

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOMA CELL; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029970464     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.444983.x     Document Type: Article

References (34)

1. Agematsu, K., Takeuchi, S., Ichikawa, M., Yabuhara, A., Uehara, Y., Kawai, H., Miyagawa, Y., Ishii, K., Katsuyama, T., Nakahata, T. & Komiyama, A. (1991) Spontaneous production of interleukin-6 by Ki-1 positive large-cell anaplastic lymphoma with extensive bone destruction. Blood, 77, 2299-2305.
2. Caracciolo, D., Clark, S.C. & Rovera, G. (1989) Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. Blood, 73, 666-670.
3. Chomozynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidium thiocynate-phenol-chloroform extraction. Analytical Biochemistry, 62, 156-159.
4. Emilie, D., Coumbaras, J., Raphael, M., Devergne, O., Delecluse, H.J., Gisselbrecht, C., Michiels, J.F., Van Damme, J., Taga, T., Kishimoto, T., Crevon, M.C. & Galanaud, P. (1992) Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood, 80, 498-504.
5. Emilie, D., Wijdenes, J., Gisselbrecht, C., Jarrousse, B., Billaud, E., Blay, J.Y., Gabarre, J., Gaillard, J.P., Brochier, J., Raphael, M., Boue, F. & Galanaud, P. (1994) Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect of lymphoma growth and on B clinical symptoms. Blood, 84, 2472-2479.
6. Foss, H.D., Herbst, H., Oelmann, E., Samol, J., Grebe, M., Blankenstein, T., Matthes, J., Qin, Z.H., Falini, B., Pileri, S., Diamanstein, T. & Stein, H. (1993) Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. British Journal of Haematology, 84, 627-635.
7. Freeman, G.J., Freedman, A.S., Rabinowe, S.N., Segil, J.M., Horowitz, J., Rosen, K., Whitman, J.E. & Nadler, L.M. (1989) Interleukin-6 gene expression in normal and neoplastic B cells. Journal of Clinical Investigation, 83, 1512-1518.
8. Gardner, J.D., Liechty, K.W. & Christensen, R.D. (1989) Effects of interleukin-6 on fetal hematopoietic progenitors. Blood, 75, 2150-2155.
9. Gauldie, D., Richards, C., Harnish, D., Landsorp, P. & Baumann, H. (1987) Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proceedings of the National Academy of Sciences of the United States of America, 84, 7251-7255.
10. Harriman, G.R., Kunimoto, D.Y., Elliott, J.F., Paetkau, V. & Strober, W. (1988) The role of IL-5 in IgA B cell differentiation. Journal of Immunology, 140, 3033-3039.
11. Ishizaka, A., Sakiyama, Y. & Nakanishi, M. (1990) The inductive effect interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes. Clinical and Experimental Immunology, 79, 392-396.
12. Janzen, J.H., Kluin-Nelemans, J.C., Van Damme, J., Wientjens, G.J.H.M., Willemze, R. & Fibbe, W.E. (1992) Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells. Journal of Experimental Medicine, 175, 1151-1154.
13. Jücker, M., Abts, H., Li, W., Schindler, R., Merz, H., Günther, A., Von Kalle, C., Schaadt, M., Diamantstein, T., Feller, A.C., Kreuger, G.R.F., Diehl, V., Blankenstein, T. & Tesch, H. (1991) Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood, 77, 2413-2418.
14. Kato, H., Nagasaka, T., Ichikawa, A., Kinoshita, T., Murate, T., Tsushita, K., Hotta, T. & Saito, H. (1994) Tumor necrosis factor-β gene expression and its relationship to the clinical features and histopathogenesis of peripheral T-cell lymphomas. Leukemia and Lymphoma, 16, 125-133.
15. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horri, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Automne generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83-85.
16. Kinoshita, T., Imamura, J., Nagai, H., Shimotohno, K. (1992) Quantitation of gene expression over a wide range of polymerase chain reaction. Analytical Biochemistry, 206, 231-235.
17. Kinoshita, T., Shimoyama, M., Tobinai, K., Itoh, M., Itoh, S., Ikeda, S., Tajima, K., Shimotohno, K. & Sugimura, T. (1989) Detection of mRNA for tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proceedings of the National Academy of Sciences of the United States of America, 86, 5620-5624.
18. Kishimoto, T. (1989) The biology of interleukin-6. Blood, 74, 1-10.
19. Klein, B., Wijdenes, J., Zhang, X.G., Jourdan, M., Boiron, J.M., Brochier, J., Liautard, J., Merlin, M., Clement, C., Morel-Fournier, B., Lu, Z.Y., Mannoni, P., Sany, J. & Bataille, R. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood, 78, 1198-1204.
20. Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. & Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
21. Koike, K., Nakahata, T., Takagi, M., Kobayashi, T., Ishiguro, A., Tsuji, K., Naganuma, K., Okano, A., Akiyama, Y. & Akabane, T. (1988) Synergism of BSF-2/interleukin-6 and interleukin-3 on development of multipotential hemopoietic progenitors in serum free culture. Journal of Experimental Medicine, 168, 879-890.
22. Kuby, J. (1994) Role of cytokines in the inflammatory response Immunology, 2nd edn (ed. by J. Kuby), pp. 313-315. W. H. Freeman and Company, New York.
23. Kurzrock, R., Redman, J., Catanillas, F., Jones, D., Rothberg, J. & Talpaz, M. (1993) Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Research, 53, 2118-2122.
24. Mulé, J.J., Marcus, S.G., Yang, J.C., Weber, J.S. & Rosenberg, S.A. (1992) Clinical application of IL-6 in cancer therapy. Research of Immunology, 143, 777-779.
25. Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K. & Kishimoto, T. (1988) The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. Journal of Experimental Medicine, 167, 332-344.
26. Ohnishi, K., Ichikawa, A., Kagami, Y., Nagasaka, T., Niwa, T., Hotta, T. & Saito, H. (1990) Interleukin 4 and γ-interferon may play a role in the histopathogenesis of peripheral T-cell lymphoma. Cancer Research, 50, 8028-8033.
27. Paul, W.E. & Ohara, J. (1987) B-cell stimulatory factor-1/ interleukin-4. Annual Review of Immunology, 5, 429-459.
28. Pelliniemi, T.T., Irjala, K., Pulkki, K., Rajamäki, A., Tienhaara, A., Laakso, M. & Lahtinen, R. (1995) Immunoreactive Interleukin-6 and acute phase protein as prognostic factors in multiple myeloma. Blood, 85, 765-771.
29. Rennick, D., Jackson, J., Yang, G., Wideman, J., Lee, F. & Hudak, S. (1989) Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakariocytic, erythroid, myeloid, and multipotential progenitor cells. Blood, 73, 1828-1835.
30. Seymour, J.F., Talpaz, M., Cabanillas, F., Wetzler, M. & Kurzrock, R. (1995) Serum Interleukin-6 levels correlate with prognosis in diffuse large cell lymphoma. Journal of Clinical Oncology, 13, 575-582.
31. Shimizu, S., Hirano, T., Yoshioka, R., Sugai, S., Matsuda, T., Taga, T., Kishimoto, T. & Konda, S. (1988) Interleukin-6 (B cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). Blood, 72, 1826-1828.
32. Tabibzadeh, S.S., Pounidis, D., May, L.T. & Sehgal, P.B. (1989) Interleukin-6 immunoreactivity in human tumors. American Journal of Pathology, 135, 427-433.
33. Yee, C., Biondi, A., Wang, X.H., Iscove, N.N., Sousa, J., Aarden, L.A., Wang, G.G., Clark, S.C., Messner, H.A. & Minden, M.D. (1989) A possible automne role for interleukin-6 in two lymphoma cell lines. Blood, 74, 798-804.
34. Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., Komori, T., Kishimoto, S., Hirano, T. & Kishimoto, T. (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood, 74, 1360-1367.